drugset / Trial / NCT05474924

The Role of Budesonide Intrapolyp Injection in CRSwNP

NCT05474924

Phase 4 Unknown 90 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Chronic rhinosinusitis with nasal polyps is a common nasal comorbidity with a wide range of symptoms that might cause severe distress and disabilities for patients. Many patients undergo repeated courses of systemic steroids and are exposed to various adverse effects. many cases finally revert to surgery. Budesonide was safely used as a nasal wash in cases of nasal polyps, our aim to determine If intrapolyp injection is a better method for delivering budesonide.

Timeline

Start
2022-08-01
Primary completion
2022-09-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 0.5 mg Other
Comparator Prednisolone Other / unclassified 1 mg/kg Oral

Indications